Alpha Cognition Proclaims Fourth Quarter and Full 12 months 2022 Outcomes and Gives Company Replace
Article content material VANCOUVER, British Columbia — Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Firm”), a biopharmaceutical firm dedicated to growing novel therapies with the potential…